France-based Intrasense is offering a worldwide free license to Myrian—a software platform that facilitates diagnosis, decision-making, and therapeutic follow-up supporting all types of imaging modalities—for clinical apps relevant for diagnosing COVID-19. In addition to a new dedicated COVID-19 reading protocol, the relevant apps are conventional radiology visualization (XM-XR), clinical scanner visualization (XM-CT), and pulmonary segmentation (XP-Lung).
Following the recommendations issued by the major international professional medical societies, such as the American College of Radiology or the Société Française de Radiologie, which define the role of medical imaging in the diagnosis and followup of patients with COVID-19, Intrasense developed a specific reading protocol based on the pulmonary application XP-Lung of the Myrian platform.
This protocol includes clinical key points, particularly about screening, analysis of the pathological stages, and clinical evolutions. Myrian automatically and intuitively provides an objective measurement of the impairment and of the available pulmonary reserve of patients, allowing rapid identification of healthy and pathological areas (ground glass opacities, condensations, crazy paving, emphysematous areas). These elements provide the pulmonary reserve as well as a density histogram over a complete pulmonary volume.
For more information, visit Intrasense.
Featured image: Transmission electron microphotograph of SARS-CoV-2 virus particles isolated from a patient. Image captured and color-enhanced at the NIAID integrated research facility in Fort Detrick, Md. Photograph courtesy NIAID.